This meeting would not be possible without the generous support of our sponsors, for whom we are very grateful. Sponsors will exhibit their products at the meeting and will have representatives ready to talk to you about your needs.
Exhibit location and times: TBD.
The global leader in brain-computer interface (BCI technology), Blackrock Neurotech pioneered the implantable neurotech space with brain tech that restores function in people with paralysis and neurological disorders like ALS and epilepsy. Our BCI technology is in humans now – our patients have been able to move and feel again, type, make music, even create art. In addition to BCIs, we build implantable tools and microelectronics that diagnose and treat neurological disorders as well as research tools that have empowered thousands of published studies and groundbreaking innovations at hundreds of institutions around the world.
630 Komas Drive | Suite 200 | Salt Lake City | UT 84108 | USA
Ad-Tech's devices are used in surgical cases for SEEG, long-term EEG monitoring, brain mapping, and brain stimulation of persons with intractable epilepsy and other brain diseases/disorders. Ad-Tech proprietary designs include subdural strip and grid electrodes, depth electrodes, depth electrodes with micro contacts, intraoperative electrodes, spinal electrodes, biopsy needles, as well as related products including electrode placement kits/accessory.
With over 40 years of designing and manufacturing high-quality medical devices, Ad-Tech has cultivated a reputation for innovative designs, quality driven manufacturing, proven performance and safe and effective devices in the field of neuro-monitoring and neurosurgery. Ad-Tech's reputation for innovative designs dates back to 1985, with the creation of strip electrodes for long-term monitoring in the treatment of intractable epilepsy. Ad-Tech's depth electrode design is considered the "gold standard" in its field. With this great history we proudly share our mission, "the patient is our thought in device design through device use."
With 50 years of experience, DIXI medical is at the forefront of innovation, providing clinicians with reliable, cutting-edge solutions that improve patient outcomes in the treatment of drug-resistant epilepsy. Headquartered in Chaudefontaine, France, the company’s dedication to advancing care is matched by its commitment to continuous improvement, ensuring that its solutions meet the evolving needs of the medical community.